Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699969011 | Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699970012 | Naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing only naloxone and pentazocine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pentazocine hydrochloride | true | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Naloxone hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing pentazocine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Opiate agonist-antagonist (substance) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pentazocine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Naloxone hydrochloride + pentazocine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Naloxone hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Chelating agent | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pentazocine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Opiate agonist-antagonist (substance) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Naloxone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing pentazocine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pentazocine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Naloxone hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Naloxone hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Naloxone hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 0,5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Pentazocine hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Pentazocine hydrochloride | true | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 50 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Pentazocine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Naloxone hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Product containing naloxone and pentazocine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR